Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhavin Shah

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Annali Di Chimica|February 4, 2005
Validation of LC/MS electrospray ionisation method for the estimation of ursodiol in human plasma and its application in bioequivalence studySonu Sundd Singh, Hiten Shah, Sapna Gupta, et al.
Molecular Cancer Therapeutics|July 24, 2014
BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITDWarren Fiskus, Sunil Sharma, Jun Qi, et al.
The Journal of Experimental Medicine|April 16, 2008
Regulation of inflammatory responses by IL-17FXuexian O Yang, Seon Hee Chang, Heon Park, et al.
Nature Neuroscience|January 29, 2021
Oligodendrocyte precursor cell specification is regulated by bidirectional neural progenitor-endothelial cell crosstalkIsidora Paredes, José Ricardo Vieira, Bhavin Shah, et al.
Oncotarget|July 16, 2014
Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cellsKyungsoo Ha, Warren Fiskus, Dong Soon Choi, et al.
Immunity|January 1, 2008
T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gammaXuexian O Yang, Bhanu P Pappu, Roza Nurieva, et al.
Immunity|July 1, 2008
Molecular antagonism and plasticity of regulatory and inflammatory T cell programsXuexian O Yang, Roza Nurieva, Gustavo J Martinez, et al.
Blood|August 9, 2015
Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinibBaohua Sun, Bhavin Shah, Warren Fiskus, et al.
Molecular Cancer Therapeutics|January 18, 2014
Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cellsWarren Fiskus, Sunil Sharma, Jun Qi, et al.
Neuron|December 22, 2022
Endothelial PlexinD1 signaling instructs spinal cord vascularization and motor neuron developmentJosé Ricardo Vieira, Bhavin Shah, Sebastian Dupraz, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Annali Di Chimica|February 4, 2005
Validation of LC/MS electrospray ionisation method for the estimation of ursodiol in human plasma and its application in bioequivalence studySonu Sundd Singh, Hiten Shah, Sapna Gupta, et al.
Molecular Cancer Therapeutics|July 24, 2014
BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITDWarren Fiskus, Sunil Sharma, Jun Qi, et al.
The Journal of Experimental Medicine|April 16, 2008
Regulation of inflammatory responses by IL-17FXuexian O Yang, Seon Hee Chang, Heon Park, et al.
Nature Neuroscience|January 29, 2021
Oligodendrocyte precursor cell specification is regulated by bidirectional neural progenitor-endothelial cell crosstalkIsidora Paredes, José Ricardo Vieira, Bhavin Shah, et al.
Oncotarget|July 16, 2014
Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cellsKyungsoo Ha, Warren Fiskus, Dong Soon Choi, et al.
Immunity|January 1, 2008
T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gammaXuexian O Yang, Bhanu P Pappu, Roza Nurieva, et al.
Immunity|July 1, 2008
Molecular antagonism and plasticity of regulatory and inflammatory T cell programsXuexian O Yang, Roza Nurieva, Gustavo J Martinez, et al.
Blood|August 9, 2015
Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinibBaohua Sun, Bhavin Shah, Warren Fiskus, et al.
Molecular Cancer Therapeutics|January 18, 2014
Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cellsWarren Fiskus, Sunil Sharma, Jun Qi, et al.
Neuron|December 22, 2022
Endothelial PlexinD1 signaling instructs spinal cord vascularization and motor neuron developmentJosé Ricardo Vieira, Bhavin Shah, Sebastian Dupraz, et al.
Pageof 5